Nabriva Therapeutics PLC (NASDAQ:NBRV)

0.793
Delayed Data
As of 5:26pm ET
 +0.0436 / +5.82%
Today’s Change
0.49
Today|||52-Week Range
2.77
-39.92%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Nabriva Therapeutics PLC have a median target of 2.25, with a high estimate of 7.00 and a low estimate of 1.00. The median estimate represents a +183.73% increase from the last price of 0.79.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Hold stock in Nabriva Therapeutics PLC. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.17
Sales
$400.0K
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 34.00%
 
 
 
 
 
 
Growthannually 36.16%
 
 
 
 
 
 

Sales

Growthquarterly -49.30%
 
 
 
 
 
 
Growthannually -45.31%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.